<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Synapse Biomedical, Inc. 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=30174></link><description><![CDATA[Synapse Biomedical, Inc. 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Wed, 29 Apr 2026 09:56:13 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><language>ko-KR</language><item><title><![CDATA[Synapse Biomedical Inc. Receives CE Approval for TransAeris, the First Medical Device Approved for the Treatment of Ventilator Induced Diaphragm Dysfunction (VIDD)]]></title><link>https://www.newswire.co.kr/newsRead.php?no=862666</link><description><![CDATA[OBERLIN, Ohio--(Business Wire/Korea Newswire)--Synapse Biomedical , an innovator in neurostimulation and manufacturer of the NeuRx Diaphragm Pacing System®, announced today, the CE Mark approval for the TransAeris™ System. TransAeris is a temporary diaphragm stimulator, for use in intensive care unit (ICU) patients on mechanical ventilation (MV). While MV provides life sustaining respiration...]]></description><pubDate>Tue, 09 Jan 2018 11:35:00 +0900</pubDate></item><item><title><![CDATA[시냅스 바이오메디컬, VIDD 치료 의료기 ‘트랜스에어리스’로 CE마크 획득]]></title><link>https://www.newswire.co.kr/newsRead.php?no=862667</link><description><![CDATA[오벌린, 오하이오--(Business Wire/뉴스와이어)--신경 자극 기술 혁신 기업이며 ‘뉴Rx 다이어프램 페이싱 시스템(NeuRx Diaphragm Pacing System®)’ 제조업체인 시냅스 바이오메디컬(Synapse Biomedical, 이하 ‘시냅스’)이 ‘트랜스에어리스 시스템(TransAeris™ System)’에 대한 CE마크를 획득했다고 8일 발표했다.  ‘트랜스에어리스’는 중환자실(ICU)에서 기계적 인공호흡(MV)을 하는 환자들을 위해 사용하는 일시적 가로막...]]></description><pubDate>Tue, 09 Jan 2018 11:35:00 +0900</pubDate></item></channel></rss>